Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)

SHA:688266 Statistics

Total Valuation

SHA:688266 has a market cap or net worth of CNY 29.78 billion. The enterprise value is 28.77 billion.

Market Cap	29.78B
Enterprise Value	28.77B

Important Dates

The last earnings date was Saturday, August 23, 2025.

Earnings Date	Aug 23, 2025
Ex-Dividend Date	n/a

Share Statistics

SHA:688266 has 264.71 million shares outstanding. The number of shares has decreased by -0.94% in one year.

Current Share Class	264.71M
Shares Outstanding	264.71M
Shares Change (YoY)	-0.94%
Shares Change (QoQ)	+2.40%
Owned by Insiders (%)	29.35%
Owned by Institutions (%)	26.01%
Float	151.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	44.59
PB Ratio	25.31
P/TBV Ratio	26.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-199.63
EV / Sales	43.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-133.12

Financial Position

The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.97.

Current Ratio	1.90
Quick Ratio	1.74
Debt / Equity	0.97
Debt / EBITDA	n/a
Debt / FCF	-5.27
Interest Coverage	-8.49

Financial Efficiency

Return on equity (ROE) is -10.81% and return on invested capital (ROIC) is -6.01%.

Return on Equity (ROE)	-10.81%
Return on Assets (ROA)	-4.77%
Return on Invested Capital (ROIC)	-6.01%
Return on Capital Employed (ROCE)	-14.05%
Revenue Per Employee	733,965
Profits Per Employee	-158,350
Employee Count	910
Asset Turnover	0.22
Inventory Turnover	0.41

Taxes

Income Tax	-4.63M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +82.99% in the last 52 weeks. The beta is 0.11, so SHA:688266's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	+82.99%
50-Day Moving Average	114.42
200-Day Moving Average	93.44
Relative Strength Index (RSI)	51.55
Average Volume (20 Days)	5,222,060

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688266 had revenue of CNY 667.91 million and -144.10 million in losses. Loss per share was -0.55.

Revenue	667.91M
Gross Profit	605.65M
Operating Income	-232.87M
Pretax Income	-152.97M
Net Income	-144.10M
EBITDA	-187.22M
EBIT	-232.87M
Loss Per Share	-0.55

Balance Sheet

The company has 2.15 billion in cash and 1.14 billion in debt, giving a net cash position of 1.01 billion or 3.83 per share.

Cash & Cash Equivalents	2.15B
Total Debt	1.14B
Net Cash	1.01B
Net Cash Per Share	3.83
Equity (Book Value)	1.18B
Book Value Per Share	4.44
Working Capital	1.21B

Cash Flow

In the last 12 months, operating cash flow was -91.37 million and capital expenditures -124.73 million, giving a free cash flow of -216.10 million.

Operating Cash Flow	-91.37M
Capital Expenditures	-124.73M
Free Cash Flow	-216.10M
FCF Per Share	-0.82

Margins

Gross margin is 90.68%, with operating and profit margins of -34.87% and -21.57%.

Gross Margin	90.68%
Operating Margin	-34.87%
Pretax Margin	-22.90%
Profit Margin	-21.57%
EBITDA Margin	-28.03%
EBIT Margin	-34.87%
FCF Margin	n/a

Dividends & Yields

SHA:688266 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.94%
Shareholder Yield	n/a
Earnings Yield	-0.48%
FCF Yield	-0.73%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SHA:688266 has an Altman Z-Score of 5.96 and a Piotroski F-Score of 2.

Altman Z-Score	5.96
Piotroski F-Score	2